Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-16
2011-08-16
Audet, Maury (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C424S001690
Reexamination Certificate
active
07998923
ABSTRACT:
Particles are bioactivated by attaching bioactivation peptides to the particle surface. The bioactivation peptides are peptide-based compounds that impart one or more biologically important functions to the particles. Each bioactivation peptide includes a molecular or surface recognition part that binds with the surface of the particle and one or more functional parts. The surface recognition part includes an amino-end and a carboxy-end and is composed of one or more hydrophobic spacers and one or more binding clusters. The functional part(s) is attached to the surface recognition part at the amino-end and/or said carboxy-end.
REFERENCES:
patent: 4795698 (1989-01-01), Owen et al.
patent: 5186827 (1993-02-01), Liberti et al.
patent: 5200084 (1993-04-01), Liberti et al.
patent: 5262357 (1993-11-01), Alivisatos et al.
patent: 5466574 (1995-11-01), Liberti et al.
patent: 5505928 (1996-04-01), Alivisatos et al.
patent: 5512332 (1996-04-01), Liberti et al.
patent: 5541072 (1996-07-01), Wang et al.
patent: 5567326 (1996-10-01), Ekenberg et al.
patent: 5698271 (1997-12-01), Liberti et al.
patent: 5751018 (1998-05-01), Alivisatos et al.
patent: 5795470 (1998-08-01), Wang et al.
patent: 5866099 (1999-02-01), Owen et al.
patent: 5990479 (1999-11-01), Weiss et al.
patent: 6114038 (2000-09-01), Castro et al.
patent: 6120856 (2000-09-01), Liberti et al.
patent: 6194213 (2001-02-01), Barbera-Guillem
patent: 6207392 (2001-03-01), Weiss et al.
patent: 6221602 (2001-04-01), Barbera-Guillem et al.
patent: 6261779 (2001-07-01), Barbera-Guillem et al.
patent: 6274323 (2001-08-01), Bruchez et al.
patent: 6306610 (2001-10-01), Bawendi et al.
patent: 6319607 (2001-11-01), Barbera-Guillem et al.
patent: 6326144 (2001-12-01), Bawendi et al.
patent: 6333110 (2001-12-01), Barbera-Guillem
patent: 6365362 (2002-04-01), Terstappen et al.
patent: 6423551 (2002-07-01), Weiss et al.
patent: 6444143 (2002-09-01), Bawendi et al.
patent: 6468808 (2002-10-01), Nie et al.
patent: 6544732 (2003-04-01), Chee et al.
patent: 6620627 (2003-09-01), Liberti et al.
patent: 6623982 (2003-09-01), Liberti et al.
patent: 6630307 (2003-10-01), Bruchez et al.
patent: 6645731 (2003-11-01), Terstappen et al.
patent: 6649138 (2003-11-01), Adams et al.
patent: 6767702 (2004-07-01), Mirkin et al.
patent: 6777186 (2004-08-01), Mirkin et al.
patent: 6815064 (2004-11-01), Treadway et al.
patent: 6838243 (2005-01-01), Lai et al.
patent: 6955855 (2005-10-01), Naasani
patent: 7172791 (2007-02-01), Treadway et al.
patent: 7198847 (2007-04-01), Naasani
patent: 7205048 (2007-04-01), Naasani
patent: 7214428 (2007-05-01), Naasani
patent: 7368086 (2008-05-01), Naasani
patent: 2001/0034034 (2001-10-01), Bruchez et al.
patent: 2002/0009728 (2002-01-01), Bittner et al.
patent: 2002/0028457 (2002-03-01), Empedocles et al.
patent: 2002/0127224 (2002-09-01), Chen
patent: 2002/0150905 (2002-10-01), Barbera-Guillem et al.
patent: 2003/0008414 (2003-01-01), Nie et al.
patent: 2003/0027214 (2003-02-01), Kamb
patent: 2003/0082237 (2003-05-01), Cha et al.
patent: 2003/0099940 (2003-05-01), Empedocles et al.
patent: 2003/0113709 (2003-06-01), Alivisatos et al.
patent: 2003/0129590 (2003-07-01), Rosenthall et al.
patent: 2003/0129591 (2003-07-01), Rosenthall et al.
patent: 2003/0148544 (2003-08-01), Nie et al.
patent: 2003/0165951 (2003-09-01), Bruchez, Jr. et al.
patent: 2003/0175773 (2003-09-01), Chee et al.
patent: 2004/0007169 (2004-01-01), Ohtsu et al.
patent: 2004/0009911 (2004-01-01), Harris et al.
patent: 2004/0014060 (2004-01-01), Hoheisel et al.
patent: 2004/0023415 (2004-02-01), Sokolov et al.
patent: 2004/0038307 (2004-02-01), Lee et al.
patent: 2004/0158051 (2004-08-01), Ozkan et al.
patent: 2004/0166505 (2004-08-01), Bruchez et al.
patent: 2004/0171039 (2004-09-01), Bruchez et al.
patent: 2004/0180380 (2004-09-01), Lee et al.
patent: 2005/0054004 (2005-03-01), Alivisatos et al.
patent: 2005/0059031 (2005-03-01), Bruchez et al.
patent: 2007/0172427 (2007-07-01), Barchi et al.
patent: 2008/0039816 (2008-02-01), Svarovsky et al.
patent: 2009/0253211 (2009-10-01), Weiss et al.
patent: 03 799 767.3-2107 (2008-08-01), None
patent: 2342651 (2000-04-01), None
patent: 2002-525394 (2002-08-01), None
patent: WO 00/17655 (2000-03-01), None
patent: WO 00/27365 (2000-05-01), None
patent: WO2004/039830 (2004-05-01), None
patent: WO2004/039830 (2005-02-01), None
patent: PCT/US2003/014401 (2005-03-01), None
patent: WO2005/053649 (2005-06-01), None
patent: WO 2005/053649 (2005-06-01), None
patent: WO2005/093422 (2005-10-01), None
patent: WO 2005/093422 (2005-10-01), None
patent: WO 2005/093422 (2005-10-01), None
patent: WO 2006/093516 (2006-09-01), None
Peng, et al., Epitaxial Growth of Highly Luminescent CdSe/CdS; Core/Shell Nanocrystals with Photostability and Electronic Accessibility; Journal of the American Chemical Society, vol. 119, No. 30, 1997; pp. 7019-7029.
Akerman et al., “Nanocrystal Targeting In Vivo”, Proc. Natl. Acad. Sci., v.99, n. 20 (Oct. 1, 2002) pp. 12617-12621.
PCT/US2005/009344 “Notification Concerning Transmittal of Int'l Prelim. Report on Patentability” and “Written Opinion of the ISA”, mailed Oct. 5, 2006, U.S. Department of Health and Human Services.
Iyer et al. Solubilization of Quantum Dots with Recombinant Peptide andEscherichia coli.2007.Small.3(5): 793-798.
Kyte, J, Doolittle, R. A Simple Method for Displaying the Hydropathic Character of a Protein. 1982.J Mol Biol.157: 105-132.
Hammes, BS, Carrano, CJ. Methylation of (2-Methylethanethiol-bis-3,5-dimethylpyrazolyl) methane Zinc Complexes and Coordination of the Resulting Thioether: Relevance to Zinc-Containing Alkyl Transfer Enzymes. 2001.lnorg Chem.40:919-927.
Tobin et al. Structural Characterization of the Zinc Site in Protein Farnesyltransferase. 2003.J Am Chem Soc.125(33):9962-9969.
Myers et al. Metal Coordination Sphere in the Methylated Ada Protein-DNA co-complex. 1994.Chemistry & Biology.1(2): 91-97.
Huang et al. Evidence for a Catalytic Role of Zinc in Protein Farnesyltransferase. 1997.Journal of Biological Chemistry.272(1):20-23.
International Search Report, date, issued in PCT/US2003/34897, mailed Aug. 20, 2004, U.S. Department of Health and Human Services.
International Search Report and Written Opinion of the International Searching Authority, issued in PCT/US2005/009344, mailed Dec. 21, 2005, U.S. Department of Health and Human Services.
International Preliminary Report on Patentability, issued in PCT/US2005/009344, mailed Oct. 5, 2006, U.S. Department of Health and Human Services.
International Preliminary Report on Patentability in PCT/US2005/022102, Dec. 28, 2006, The Regents of the University of California.
Written Opinion of the International Search Authority in PCT/US2005/022102, Nov. 7, 2006, The Regents of University of California.
International Search Report dated Nov. 7, 2006, issued in Nov. 7, 2006, issued in PCT/US2005/022102, mailed Nov. 7, 2006, The Regents of the University of California.
Vahrenkamp, H. Transitions, Transition States, Transition State Analogues: Zinc Pyrazolylborate Chemistry Related to Zinc Enzymes. 1999.Acc Chem Res.32:589-596.
Pinaud et al. Bioactivation and Cell Targeting of Semiconductor CdSe/ZnS Nanocrystals with Phytochelatin-Related Peptides. 2004.J Am Chem Soc.126, 6115-6123.
Wu et al. Immunofluorescent Labeling of Cancer Marker Her2 and other Cellular Targets with Semiconductor Quantum Dots. 2003.Nature Biotechnology.21:41-46.
Kyte, J. et al., “A Simple Method for Displaying the Hydropathic Character of a Protein”, J. Mol. Biol. 157 (1982) 105-132.
Pinaud et al., “Supporting information for Bioactivation and Cell Targeting of Semiconductor CdSe/ZnS Nanocrystals with Phytochelatin-related Peptides”, S-1- S-11, published online (Web) at http://pubs.acs.org/doi/suppl—10.1021/ja031691c (file http://pubs.acs.org/doi/suppl/10.1021/ja031691c/suppl—file/ja031691csi20040223—054743.pdf) on Apr. 22, 2004, together with Pinaud et al., “Bioactivation and Cell Targeting of Semiconductor CdSe/ZnS Nanocyrstals with Phytochelatin-Related Pepti
King David
Pinaud Fabien
Weiss Shimon
Audet Maury
Genieser Lars H.
Gollin Michael A.
The Regents of the University of California
Venable LLP
LandOfFree
Bioactivation of particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactivation of particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactivation of particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705336